Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Liapakis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry|October 12, 2000
Template-constrained cyclic peptide analogues of somatostatin: subtype-selective binding to somatostatin receptors and antiangiogenic activityD J Suich, S A Mousa, G Singh, et al.
The Journal of Biological Chemistry|August 31, 2000
The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptorG Liapakis, J A Ballesteros, S Papachristou, et al.
Molecular Pharmacology|July 1, 1999
Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6S G Rasmussen, A D Jensen, G Liapakis, et al.
Journal of Neuroendocrinology|May 1, 2004
Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behavioursM Venihaki, S Sakihara, S Subramanian, et al.
The Journal of Biological Chemistry|May 29, 2001
Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6J A Ballesteros, A D Jensen, G Liapakis, et al.
Journal of Medicinal Chemistry|July 4, 1997
Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studiesG Osapay, L Prokai, H S Kim, et al.
Endocrinology|January 6, 2001
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulinM Afargan, E T Janson, G Gelerman, et al.
Journal of Neuroscience Research|June 22, 1999
Structural and compositional determinants of cortistatin activityJ R Criado, H Li, X Jiang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry|October 12, 2000
Template-constrained cyclic peptide analogues of somatostatin: subtype-selective binding to somatostatin receptors and antiangiogenic activityD J Suich, S A Mousa, G Singh, et al.
The Journal of Biological Chemistry|August 31, 2000
The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptorG Liapakis, J A Ballesteros, S Papachristou, et al.
Molecular Pharmacology|July 1, 1999
Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6S G Rasmussen, A D Jensen, G Liapakis, et al.
Journal of Neuroendocrinology|May 1, 2004
Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behavioursM Venihaki, S Sakihara, S Subramanian, et al.
The Journal of Biological Chemistry|May 29, 2001
Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6J A Ballesteros, A D Jensen, G Liapakis, et al.
Journal of Medicinal Chemistry|July 4, 1997
Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studiesG Osapay, L Prokai, H S Kim, et al.
Endocrinology|January 6, 2001
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulinM Afargan, E T Janson, G Gelerman, et al.
Journal of Neuroscience Research|June 22, 1999
Structural and compositional determinants of cortistatin activityJ R Criado, H Li, X Jiang, et al.
Pageof 2